Aura Biosciences Inc.

NASDAQ: AURA · Real-Time Price · USD
6.73
-0.27 (-3.86%)
At close: Aug 15, 2025, 3:59 PM
6.85
1.78%
After-hours: Aug 15, 2025, 05:02 PM EDT

Aura Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 2.06M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
300K n/a 291K n/a 313K 306K 324K 400K 300K 328K 323K 302K 296K 256K 230K 218K 200K 268K
Gross Profit
-300K n/a n/a n/a -313K -306K 1.73M -400K -300K -328K -323K -302K -296K -256K -230K -218K -200K -268K
Operating Income
-28.61M n/a -27.81M -23.23M -22.76M -22.31M -24.78M -18.51M -20.28M -19.44M -17.61M -16.05M -13.82M -12.81M -11.63M -8.89M -8.8M -5.93M
Interest Income
1.68M n/a 2.03M 2.26M 2.45M 2.69M 2.61M 1.98M 2.01M 1.99M 1.06M 483K 292K n/a 5K 5K n/a n/a
Pretax Income
-26.97M -27.46M -25.81M -21M -20.34M -19.66M -21.99M -18.51M -18.3M -17.47M -16.56M -15.9M -13.47M -12.84M -11.63M -8.84M -8.85M -5.93M
Net Income
-27.02M -27.48M -25.83M -21.04M -20.34M -19.71M -22.13M -18.51M -18.3M -15.16M -41.81M -15.75M -13.47M -12.86M -11.63M -8.84M -8.85M -5.93M
Selling & General & Admin
5.43M 5.69M 5.47M 6.2M 5.88M 4.96M 4.18M 5.06M 5.16M 5.04M 4.45M 4.76M 4.31M 4.54M 3.65M 2.53M 2.17M 1.74M
Research & Development
22.88M 23.34M 22.33M 17.04M 16.88M 17.05M 20.28M 15.43M 15.12M 14.4M 13.16M 11.29M 9.51M 8.28M 7.98M 6.37M 6.63M 4.18M
Other Expenses
n/a n/a n/a n/a n/a -32K -26K -5K -32K -13K -8K -7K -5K n/a n/a 52K n/a n/a
Operating Expenses
28.31M 29.04M 27.52M 23.23M 22.76M 22.01M 24.46M 20.49M 20.28M 19.44M 17.61M 16.05M 13.82M 12.81M 11.63M 8.89M 8.8M 5.93M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 25K 13K n/a 4K 1K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -306K -324K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
28.61M n/a 28.73M 23.23M 22.76M 22.31M 24.78M 20.49M 20.28M 19.44M 17.61M 16.05M 13.82M 12.81M 11.63M 8.89M 8.8M 5.93M
Income Tax Expense
48K -18K 24K 43K n/a 46K 137K -348K n/a -2.31M 25.25M -154K n/a 24K n/a -57K 51K n/a
Shares Outstanding (Basic)
58.02M 50.13M 49.65M 49.66M 49.55M 49.45M 44.44M 38.19M 37.86M 37.78M 31.85M 29.27M 29.25M 29.21M 28.01M 28.01M 19.57M 19.57M
Shares Outstanding (Diluted)
58.02M 50.13M 49.65M 49.66M 49.55M 49.45M 44.44M 38.19M 37.86M 37.78M 31.85M 29.27M 29.25M 29.21M 28.01M 28.01M 19.57M 19.57M
EPS (Basic)
-0.47 -0.55 -0.52 -0.42 -0.41 -0.4 -0.5 -0.48 -0.48 -0.4 -1.31 -0.54 -0.46 -0.44 -0.42 -0.32 -0.45 -0.3
EPS (Diluted)
-0.47 -0.55 -0.52 -0.42 -0.41 -0.4 -0.5 -0.48 -0.48 -0.4 -1.31 -0.54 -0.46 -0.44 -0.42 -0.32 -0.45 -0.3
EBITDA
-26.67M n/a -27.52M -22.92M -22.45M -22.01M -24.46M -20.14M -19.98M -19.12M -17.29M -15.75M -13.52M -12.55M -11.4M -8.68M -8.6M -5.74M
EBIT
-26.97M n/a -25.81M -23.23M -22.76M -22.31M -24.78M -20.49M -20.28M -19.44M -17.61M -16.05M -13.82M -12.81M -11.63M -8.89M -8.8M -5.93M
Depreciation & Amortization
300K n/a 291K 313K 313K 306K 324K 400K 300K 328K 323K 302K 296K 256K 230K 218K 200K 268K